Baradaran Ghavami, S.; Asadzadeh Aghdaei, H.; Sorrentino, D.; Shahrokh, S.; Farmani, M.; Ashrafian, F.; Dore, M.P.; Keshavarz Azizi Raftar, S.; Mobin Khoramjoo, S.; Zali, M.R.
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease? Int. J. Mol. Sci. 2021, 22, 8274.
https://doi.org/10.3390/ijms22158274
AMA Style
Baradaran Ghavami S, Asadzadeh Aghdaei H, Sorrentino D, Shahrokh S, Farmani M, Ashrafian F, Dore MP, Keshavarz Azizi Raftar S, Mobin Khoramjoo S, Zali MR.
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease? International Journal of Molecular Sciences. 2021; 22(15):8274.
https://doi.org/10.3390/ijms22158274
Chicago/Turabian Style
Baradaran Ghavami, Shaghayegh, Hamid Asadzadeh Aghdaei, Dario Sorrentino, Shabnam Shahrokh, Maryam Farmani, Fatemeh Ashrafian, Maria Pina Dore, Shahrbanoo Keshavarz Azizi Raftar, Seyed Mobin Khoramjoo, and Mohammad Reza Zali.
2021. "Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?" International Journal of Molecular Sciences 22, no. 15: 8274.
https://doi.org/10.3390/ijms22158274
APA Style
Baradaran Ghavami, S., Asadzadeh Aghdaei, H., Sorrentino, D., Shahrokh, S., Farmani, M., Ashrafian, F., Dore, M. P., Keshavarz Azizi Raftar, S., Mobin Khoramjoo, S., & Zali, M. R.
(2021). Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease? International Journal of Molecular Sciences, 22(15), 8274.
https://doi.org/10.3390/ijms22158274
